(Q28268346)

https://api.crossref.org/works/10.1080/13697130500148875

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

Pharmacokinetic and pharmacological features of oestradiol valerate

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

A comparison of the pharmacokinetic properties of three estradiol esters

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/13697130500148875

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Comparison of pharmacodynamic properties of various estrogen formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Biologic effects of equilin sulfate in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Functional role of estrogen metabolism in target cells: review and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15α,16α,17β-tetrol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Pharmacokinetics of oestrogens and progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

In VivoUptake and Subcellular Distribution of Tritium- Labeled Estrogens in Human Endometrium, Myometrium, and Vagina

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Enhanced hepatic extraction of estrogens used for replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Pharmacokinetics of estradiol valerate and medroxyprogesterone acetate in different age groups of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Dose proportionality study of four doses of an estradiol transdermal system, Estradot®

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Absorption and bioavailability of oestradiol from a gel, a patch and a tablet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Biological effects of hormone replacement therapy in relation to serum estradiol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Carotid intima-media thickness in surgical menopause: women who received HRT versus who did not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Hormone replacement therapy and peripheral arterial disease: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Different effects of oral and transdermal estrogen replacement therapy on matrix metalloproteinase and their inhibitor in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Aerodiol versus the transdermal route: perspectives for patient preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Dose-ranging studies of a novel intranasal estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The acute effects of sublingual 17beta-estradiol on the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Absorption of Estrogens from Vaginal Creams

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estradiol-delivering vaginal rings for hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estradiol delivery by vaginal rings: potential for hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

New kinetic data on estradiol in light of the vaginal ring concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Local estrogen treatment in patients with urogenital symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A randomized comparison of nonoral estradiol delivery in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of 17 alpha-dihydroequilenin sulfate on atherosclerotic male and female rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Biological Effects of Various Doses of Vaginally Administered Conjugated Equine Estrogens in Postmenopausal Women*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estrogen-Induced Uterine Responses and Growth: Relationship to Receptor Estrogen Binding by Uterine Nuclei11

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Low-potency oestrogen and risk of endometrial cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Serum oestriol, oestrone and oestradiol concentrations during oral oestriol succinate treatment in ovariectomized women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Efficacy and safety of oral estriol for managing postmenopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Bone loss during oestriol therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Use of low potency estrogens does not reduce the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Review of the endometrial safety during intravaginal treatment with estriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Metabolism of stilbene estrogens and steroidal estrogens in relation to carcinogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Comparative pharmacology of newer progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Induction of amenorrhea during hormone replacement therapy: optimal micronized progesterone dose. A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A placebo-controlled study of effects of oral progesterone on performance and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Influence of route of administration on progesterone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Transvaginal administration of progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Progesterone creams: do they work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

New progestogens in oral contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Trimegestone: expanding therapeutic choices for the treatment of the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Nestorone: a progestin with a unique pharmacological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The pharmacological profile of a novel norpregnance progestin (trimegestone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effect of megestrol acetate on flushing and bone metabolism in post-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Ethinylestradiol/chlormadinone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A comparison of the potencies and activities of progestogens used in contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Oral 17beta-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Endometrial effects of transdermal estradiol/norethisterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Intrauterine application of progestins in hormone replacement therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, contro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Pharmacokinetics of tibolone in early and late postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Receptor profiling and endocrine interactions of tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Continuous combined hormone replacement therapy compared with tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Tibolone for postmenopausal women: systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users. World Health Organization. Task Force on Oral Contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Overview on the effects of progestins on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Negative mood changes during hormone replacement therapy: a comparison between two progestogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Effects of progestogens on haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Differential Permeability of Uterine and Liver Vascular Beds to Estrogens and Estrogen Conjugates*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Estriol in the Postmenopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875

Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500148875